Insider Transactions in Q2 2022 at Recursion Pharmaceuticals, Inc. (RXRX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
3,000
-0.55%
|
-
|
|
Jun 14
2022
|
R. Martin Chavez Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,145
+38.28%
|
-
|
|
Jun 14
2022
|
Terry Ann Burrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,145
+10.51%
|
-
|
|
Jun 14
2022
|
Zavain Dar Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,145
+50.0%
|
-
|
|
Jun 14
2022
|
Robert Hershberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,145
+41.1%
|
-
|
|
Jun 14
2022
|
Dean Y Li Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,145
+2.85%
|
-
|
|
Jun 14
2022
|
Blake Borgeson Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,145
+0.24%
|
-
|
|
Jun 02
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$15,000
$6.34 P/Share
|
|
Jun 02
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
|
Jun 02
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
39,690
-3.7%
|
$238,140
$6.11 P/Share
|
|
Jun 02
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+3.34%
|
-
|
|
Jun 02
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+5.49%
|
$62,500
$2.48 P/Share
|
|
May 19
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
12,000
-2.15%
|
-
|
|
May 16
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,764
-1.13%
|
$28,820
$5.67 P/Share
|
|
May 16
2022
|
Tina Marriott Larson President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,458
-0.7%
|
$7,290
$5.67 P/Share
|
|
May 16
2022
|
Michael Secora Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,069
-0.18%
|
$5,345
$5.67 P/Share
|
|
May 16
2022
|
Ramona Doyle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
832
-0.68%
|
$4,160
$5.67 P/Share
|
|
May 16
2022
|
Shafique Virani Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
870
-0.83%
|
$4,350
$5.67 P/Share
|
|
May 12
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
12,000
-2.1%
|
-
|
|
May 05
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$15,000
$6.44 P/Share
|
|
May 05
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
|
May 05
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,500
-3.49%
|
$111,000
$6.44 P/Share
|
|
May 05
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+3.37%
|
-
|
|
May 04
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$15,000
$6.47 P/Share
|
|
May 04
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
|
May 04
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
31,830
-3.01%
|
$190,980
$6.49 P/Share
|
|
May 04
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+3.37%
|
-
|
|
May 04
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+5.61%
|
$62,500
$2.48 P/Share
|
|
Apr 29
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$15,000
$6.31 P/Share
|
|
Apr 29
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
|
Apr 29
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
38,070
-3.71%
|
$228,420
$6.19 P/Share
|
|
Apr 29
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+3.48%
|
-
|
|
Apr 29
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44,014
+7.89%
|
$88,028
$2.48 P/Share
|
|
Apr 28
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$15,000
$6.06 P/Share
|
|
Apr 28
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
|
Apr 28
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
37,605
-3.85%
|
$225,630
$6.09 P/Share
|
|
Apr 28
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+3.65%
|
-
|
|
Apr 28
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44,010
+8.26%
|
$88,020
$2.48 P/Share
|
|
Apr 25
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
24,000
-2.34%
|
-
|
|
Apr 25
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
12,000
+2.56%
|
-
|
|
Apr 22
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$15,000
$6.0 P/Share
|
|
Apr 22
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
|
Apr 22
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
37,953
-4.09%
|
$227,718
$6.04 P/Share
|
|
Apr 22
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+3.84%
|
-
|
|
Apr 22
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44,010
+8.66%
|
$88,020
$2.48 P/Share
|
|
Apr 21
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$15,000
$6.18 P/Share
|
|
Apr 21
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
|
Apr 21
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
37,155
-4.23%
|
$222,930
$6.32 P/Share
|
|
Apr 21
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+4.05%
|
-
|
|
Apr 21
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44,010
+9.12%
|
$88,020
$2.48 P/Share
|